W. Rowlands
Geen lopende functies
Loopbaan van W. Rowlands
Eerdere bekende functies van W. Rowlands
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| A-LABS CAPITAL II CORP. | Directeur/Bestuurslid | 05-09-2018 | 01-07-2023 |
| Independent Dir/Board Member | 05-09-2018 | 01-07-2023 | |
| XORTX THERAPEUTICS INC. | Directeur/Bestuurslid | 09-01-2018 | 08-05-2018 |
| Voorzitter | 08-05-2018 | 20-12-2021 | |
| Independent Dir/Board Member | 09-01-2018 | 20-12-2021 | |
| Public Communications Contact | 09-01-2018 | 20-12-2021 | |
| TALISKER RESOURCES LTD. | Directeur/Bestuurslid | 15-03-2018 | 26-09-2018 |
| Algemeen Directeur | 01-04-2006 | 15-03-2018 | |
| Voorzitter | 28-06-2012 | 15-03-2018 | |
| President | 01-04-2006 | 01-08-2014 | |
| APTOSE BIOSCIENCES INC. | Public Communications Contact | 01-01-2003 | 01-01-2005 |
| Dominick & Dominick Securities, Inc. | Directeur/Bestuurslid | 01-01-1999 | 01-01-2003 |
| Corporate Officer/Principal | 01-01-1999 | 01-01-2003 | |
XORTX Pharma Corp.
 XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Directeur/Bestuurslid | 01-11-2014 | - |
Statistieken
Internationaal
| Canada | 7 |
Operationeel
| Director/Board Member | 5 |
| Public Communications Contact | 2 |
| Chairman | 2 |
Sectoraal
| Health Technology | 4 |
| Non-Energy Minerals | 2 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| TALISKER RESOURCES LTD. | Non-Energy Minerals |
| XORTX THERAPEUTICS INC. | Health Technology |
| A-LABS CAPITAL II CORP. | Finance |
| Bedrijven in privébezit | 2 |
|---|---|
XORTX Pharma Corp.
XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Health Technology |
| Dominick & Dominick Securities, Inc. |
- Beurs
- Insiders
- W. Rowlands
- Ervaring
